SNCA and Parkinson disease: Application of recombinant CLN10/CTSD (Cathepsin D) ameliorates ⍺‐synuclein aggregation and Parkinson disease pathology in ⍺‐synuclein A53T variant‐containing induced Pluripotent Stem Cells (iPSC)‐derived neurons.41